An Open Label Study of Levetiracetam in Japanese Pediatric Patients With Partial Seizures
Status:
Completed
Trial end date:
2013-10-01
Target enrollment:
Participant gender:
Summary
Objective of the First Period: To evaluate the efficacy of Levetiracetam dry syrup at doses
up to a maximum of 60 mg/kg/day or 3000 mg/day used as an adjunctive therapy in Japanese
pediatric patients (4 to 16 years) with uncontrolled partial seizures despite treatment with
1 or 2 anti-epileptic drug(s).